Cargando…
Risk factors for multidrug resistance in tuberculosis patients with diabetes mellitus
OBJECTIVE: To study the risk factors and prediction models of multidrug resistance in patients with tuberculosis and diabetes and those with a history of tuberculosis treatment. METHODS: A total of 256 tuberculosis patients with diabetes who were registered in Luoyang city, Henan Province, from Janu...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650799/ https://www.ncbi.nlm.nih.gov/pubmed/36369020 http://dx.doi.org/10.1186/s12879-022-07831-3 |
_version_ | 1784828103719124992 |
---|---|
author | Li, Shuangping Liang, Yalin Hu, Xinjun |
author_facet | Li, Shuangping Liang, Yalin Hu, Xinjun |
author_sort | Li, Shuangping |
collection | PubMed |
description | OBJECTIVE: To study the risk factors and prediction models of multidrug resistance in patients with tuberculosis and diabetes and those with a history of tuberculosis treatment. METHODS: A total of 256 tuberculosis patients with diabetes who were registered in Luoyang city, Henan Province, from January 2018 to December 2021. Logistic regression analysis was performed to analyse the risk factors for multidrug resistance. ROC curves were used to analyse the predictive model for multidrug resistance. RESULTS: Age < 65 years old, HbA1c, and a history of tuberculosis treatment were independent risk factors for multidrug resistance in patients with tuberculosis and diabetes (P < 0.05). The area under the ROC curve of predictive model for MDR was 0.878 (95% CI (0.824, 0.932)). Age < 65 years old and HbA1c were independent risk factors for MDR in patients with TB and diabetes with a history of TB treatment. The area under the ROC curve of predictive model for MDR was 0.920 [95% CI (0.831, 0.999)]. CONCLUSION: The predictive model had certain prediction value for the risk of multidrug resistance in patients with tuberculosis and diabetes. |
format | Online Article Text |
id | pubmed-9650799 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96507992022-11-15 Risk factors for multidrug resistance in tuberculosis patients with diabetes mellitus Li, Shuangping Liang, Yalin Hu, Xinjun BMC Infect Dis Research OBJECTIVE: To study the risk factors and prediction models of multidrug resistance in patients with tuberculosis and diabetes and those with a history of tuberculosis treatment. METHODS: A total of 256 tuberculosis patients with diabetes who were registered in Luoyang city, Henan Province, from January 2018 to December 2021. Logistic regression analysis was performed to analyse the risk factors for multidrug resistance. ROC curves were used to analyse the predictive model for multidrug resistance. RESULTS: Age < 65 years old, HbA1c, and a history of tuberculosis treatment were independent risk factors for multidrug resistance in patients with tuberculosis and diabetes (P < 0.05). The area under the ROC curve of predictive model for MDR was 0.878 (95% CI (0.824, 0.932)). Age < 65 years old and HbA1c were independent risk factors for MDR in patients with TB and diabetes with a history of TB treatment. The area under the ROC curve of predictive model for MDR was 0.920 [95% CI (0.831, 0.999)]. CONCLUSION: The predictive model had certain prediction value for the risk of multidrug resistance in patients with tuberculosis and diabetes. BioMed Central 2022-11-11 /pmc/articles/PMC9650799/ /pubmed/36369020 http://dx.doi.org/10.1186/s12879-022-07831-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Li, Shuangping Liang, Yalin Hu, Xinjun Risk factors for multidrug resistance in tuberculosis patients with diabetes mellitus |
title | Risk factors for multidrug resistance in tuberculosis patients with diabetes mellitus |
title_full | Risk factors for multidrug resistance in tuberculosis patients with diabetes mellitus |
title_fullStr | Risk factors for multidrug resistance in tuberculosis patients with diabetes mellitus |
title_full_unstemmed | Risk factors for multidrug resistance in tuberculosis patients with diabetes mellitus |
title_short | Risk factors for multidrug resistance in tuberculosis patients with diabetes mellitus |
title_sort | risk factors for multidrug resistance in tuberculosis patients with diabetes mellitus |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650799/ https://www.ncbi.nlm.nih.gov/pubmed/36369020 http://dx.doi.org/10.1186/s12879-022-07831-3 |
work_keys_str_mv | AT lishuangping riskfactorsformultidrugresistanceintuberculosispatientswithdiabetesmellitus AT liangyalin riskfactorsformultidrugresistanceintuberculosispatientswithdiabetesmellitus AT huxinjun riskfactorsformultidrugresistanceintuberculosispatientswithdiabetesmellitus |